BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28728985)

  • 1. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
    Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
    Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
    Lee BH; Lee DS; Cho CW; Yun SS
    World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma.
    Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS
    Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Hatano E; Uemoto S; Yamaue H; Yamamoto M;
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):395-402. PubMed ID: 30091239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H
    Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
    Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
    J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
    Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
    Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
    Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
    World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T; Mimura T; Tutui N
    J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.
    Nitta H; Beppu T; Imai K; Hayashi H; Chikamoto A; Baba H
    World J Surg; 2013 May; 37(5):1034-42. PubMed ID: 23435678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.
    Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
    Onishi H; Nouso K; Nakamura S; Katsui K; Wada N; Morimoto Y; Miyahara K; Takeuchi Y; Kuwaki K; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Kobayashi Y; Sakaguchi K; Kanazawa S; Yamamoto K
    Hepatol Int; 2015 Jan; 9(1):105-12. PubMed ID: 25788384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
    Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.
    Tsai WL; Lai KH; Liang HL; Hsu PI; Chan HH; Chen WC; Yu HC; Tsay FW; Wang HM; Tsai HC; Cheng JS
    PLoS One; 2014; 9(5):e92784. PubMed ID: 24824520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Song DS; Song MJ; Bae SH; Chung WJ; Jang JY; Kim YS; Lee SH; Park JY; Yim HJ; Cho SB; Park SY; Yang JM
    J Gastroenterol; 2015 Apr; 50(4):445-54. PubMed ID: 25027973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.